Prosecution Insights
Last updated: October 25, 2026

University of Cincinnati

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Medical Devices & Mechanical Engineering

41 pending office actions • 33 art units • 40 examiners • 0 of 41 (0%) have an AI response strategy ready • 26 patents granted in the last 365 days

Analysis

University of Cincinnati has 42 pending office actions in Biotechnology & Pharmaceuticals. The matters span 41 examiners and 33 art units, reflecting broad distribution across the examination corps and technical assignments.

SUN, CAITLYN MINGYUN handles 2 pending matters, the largest stated examiner concentration. Nearly all remaining matters are assigned elsewhere, so counsel should avoid relying on a single examiner strategy.

The scale and dispersion support a structured portfolio process. Art-unit grouping can help identify recurring issues and coordinate related applications, while examiner-level review remains necessary because the docket is distributed across many separate records.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

41
Total Pending OAs
24
Non-Final OAs
15
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 12 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

9
Overdue
0
Due this week
1
Due this month
1
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 12 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (9)Due ≤ 30 days (1)Due ≤ 60 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

21
Hard (51%)
17
Medium (41%)
3
Easy (7%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (2%)
§101 + other3 (7%)
§103 only16 (39%)
§112 only3 (7%)
Double-patenting + other1 (2%)
Multi-statute (no §101)17 (41%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

28
Life Sciences
68% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
2
Semiconductors
5% of docket
10
Mechanical / Eng
24% of docket
1
Business / Other
2% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

410 h
Manual time on pending OAs
82 h
Time saved (low, 20%)
144 h
Time saved (mid, 35%)
3.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SUN, CAITLYN MINGYUN 2 63.7% +11.8%
GONZALEZ RAMOS, MAYLA 1 54.8% +13.6%
PIHONAK, SARAH 1 61.4% +42.4%
JOHANAS, JACQUELINE T 1 63.9% +29.9%
MATTHEWS, TESSA M 1 82.9% +24.0%
SHARPLESS, CHRISTEN ALICIA 1 50.4% +27.2%
OGUNBIYI, OLUWATOSIN A 1 63.8% +41.2%
SOROUSH, LAYLA 1 40.5% +43.4%
KAUR, GURPREET 1 65.4% +35.5%
REILLY, SOPHIA JANE 1 60.0% +49.4%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18978232 Method and Device for Endoscopic Endonasal Occipitocervical Fusion MATTHEWS, TESSA M 84d overdue

Hard Cases (21)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18498616 Non-Invasive Hydrogen Monitoring to Assess Gut Health and Other Clinical Outcomes BALAJI, KAVYA SHOBANA 104d overdue
17421616 CONTINUOUS EX-VIVO AFFINITY-BASED SENSING OF INTERSTITIAL FLUID TOMBERS, JOSEPH A 59d overdue
17799556 Wavelength Supplemented Light Bulbs and Lighting Fixtures LUQUE, RENAN 3d overdue
18027391 ABRASION PROTECTED MICRONEEDLE AND INDWELLING EAB SENSORS KRETZER, KYLE W. 83d
18992233 Atlantoaxial Prosthetic Joint JOHANAS, JACQUELINE T —
18852553 Engineered Probiotic Delivery System for Anti-SARS-COV-2 Treatment and Immunity Against Viruses OGUNBIYI, OLUWATOSIN A —
18848646 METHODS OF POTENTIATING TEMOZOLOMIDE ACTIVITY AGAINST GLIOBLASTOMA CELLS SOROUSH, LAYLA —
18800769 SULFONATO RESORCINARENE-COMPLEXED FLUOROQUINOLONES AND METHODS OF USE REILLY, SOPHIA JANE —

Interview Candidates (11)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18978232 Method and Device for Endoscopic Endonasal Occipitocervical Fusion MATTHEWS, TESSA M 84d overdue
19078420 Large Scale Solar Energy Storage System-Based Advanced Materials GONZALEZ RAMOS, MAYLA 42d overdue
19046763 COMBINATION THERAPY FOR THE TREATMENT OF CANCER PIHONAK, SARAH —
18992233 Atlantoaxial Prosthetic Joint JOHANAS, JACQUELINE T —
18860508 Bed-Mounted Surgical Tool Organization System SHARPLESS, CHRISTEN ALICIA —
18852553 Engineered Probiotic Delivery System for Anti-SARS-COV-2 Treatment and Immunity Against Viruses OGUNBIYI, OLUWATOSIN A —
18848646 METHODS OF POTENTIATING TEMOZOLOMIDE ACTIVITY AGAINST GLIOBLASTOMA CELLS SOROUSH, LAYLA —
18839249 Single Waveform, Continuous Squarewave Voltammetry for Optimal Calibration Free Sensing KAUR, GURPREET —

Top Art Units

Art UnitApps
1795 3
3791 3
1627 2
3773 2
1612 2
1721 1
3795 1
1645 1
1622 1
1759 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19078420 Large Scale Solar Energy Storage System-Based Advanced Materials GONZALEZ RAMOS, MAYLA 1721 §103 Final Rejection 42d overdue Pending Mar 13, 2025
19046763 COMBINATION THERAPY FOR THE TREATMENT OF CANCER PIHONAK, SARAH 1627 §103Other Non-Final OA — Pending Feb 06, 2025
18992233 Atlantoaxial Prosthetic Joint JOHANAS, JACQUELINE T 3773 §102§103 Non-Final OA — Pending Jan 08, 2025
18978232 Method and Device for Endoscopic Endonasal Occipitocervical Fusion MATTHEWS, TESSA M 3773 §103 Final Rejection 84d overdue Pending Dec 12, 2024
18860508 Bed-Mounted Surgical Tool Organization System SHARPLESS, CHRISTEN ALICIA 3795 §103 Final Rejection — Pending Oct 25, 2024
18852553 Engineered Probiotic Delivery System for Anti-SARS-COV-2 Treatment and Immunity Against Viruses OGUNBIYI, OLUWATOSIN A 1645 §102§112Other Non-Final OA — Pending Sep 30, 2024
18848646 METHODS OF POTENTIATING TEMOZOLOMIDE ACTIVITY AGAINST GLIOBLASTOMA CELLS SOROUSH, LAYLA 1622 §102§103 Non-Final OA — Pending Sep 19, 2024
18839249 Single Waveform, Continuous Squarewave Voltammetry for Optimal Calibration Free Sensing KAUR, GURPREET 1759 §112 Non-Final OA — Pending Aug 16, 2024
18800769 SULFONATO RESORCINARENE-COMPLEXED FLUOROQUINOLONES AND METHODS OF USE REILLY, SOPHIA JANE 1627 §103§112 Non-Final OA — Pending Aug 12, 2024
18834776 Lift-Based Peel Separation for Inverted Vat Photopolymerization 3D Printing ROBITAILLE, JOHN P 1743 §102§103 Non-Final OA — Pending Jul 31, 2024
18728021 Electrochemical Aptamer Sensors with Signal Amplification Via Multiple Redox Tags QIAN, SHIZHI 1795 §102§112 Final Rejection — Pending Jul 10, 2024
18727023 METHODS FOR SELF-SEEDED HYDROTHERMAL GROWTH OF MFI ZEOLITE NANOSHEETS AND NANOSHEET ASSEMBLIES AND FOR TILING NANOSHEET ZEOLITE PLATES ON POLYMER SUPPORTS BOWMAN, ANDREW J 1717 §102§103§112 Non-Final OA — Pending Jul 05, 2024
18699494 Functionalized Linkers in Responsive Biomaterials COHEN, MICHAEL P 1612 §103§112 Non-Final OA — Pending Apr 08, 2024
18690025 Shelf-Stable Sterilization of Aptamer-Sensors for In-Vivo Measurement in Humans CONLEY, SEAN EVERETT 1799 §103 Non-Final OA — Pending Mar 07, 2024
18681618 MEMOMETER DOAN, NGHIA M — §103 Non-Final OA — Pending Feb 06, 2024
18409074 MG ALLOY MESH REINFORCED POLYMER/ECM HYBRID SCAFFOLDS FOR CRITICAL-SIZED BONE DEFECT REGENERATION HOBAN, MELISSA A 3774 §103 Non-Final OA — Pending Jan 10, 2024
18577961 Method for Making 3D-Shaped 3D Graphene MOUDOU, EILEEN QI-YUN 1738 §103§112 Non-Final OA — Pending Jan 09, 2024
18540458 Synthesis of Thiophene Derivatized Polyphenolic Calixarenes GREENE, IVAN A 1619 §103 Final Rejection 113d overdue Pending Dec 14, 2023
18517667 Compositions Incorporating Avobenzone Complexes HOLLOMAN, NANNETTE 1612 §102§103 Non-Final OA — Pending Nov 22, 2023
18498616 Non-Invasive Hydrogen Monitoring to Assess Gut Health and Other Clinical Outcomes BALAJI, KAVYA SHOBANA 3791 §102§103 Non-Final OA 104d overdue Pending Oct 31, 2023
18555940 A VACCINE ADJUVANT FOR INFECTIOUS DISEASES BARRERA, IMMACULADA 1671 §101§102§103§112 Non-Final OA — Pending Oct 18, 2023
18553997 IMPROVED ADDITIVE SOLUTION FOR WHOLE BLOOD PRESERVATION AND STORAGE NGUYEN, NGHI V 1653 §102§103DP Non-Final OA — Pending Oct 05, 2023
18268861 VERTICAL AXIS WIND TURBINES AND DEVICES THEREFOR GUGGER, SEAN A 2834 §103 Non-Final OA 32d overdue Pending Jun 21, 2023
18201179 Device and Method for Detection of Post-Surgical Infection and Other Disease DIETRICH, JOSEPH M 3796 §103 Non-Final OA — Pending May 23, 2023
18196168 C-Peptide as a Therapy for Patients with Diabetes GARYU, LIANKO G 1654 §102§103 Non-Final OA — Pending May 11, 2023
18036337 TECHNIQUES FOR COVALENT BONDING OF CARBON NANOTUBES TO SUBSTRATES PENNY, TABATHA L 1712 §103 Non-Final OA 46d Pending May 10, 2023
18027932 Method for Pleurodesis and Delivery of Drugs to the Lung and Pleural Space KWON, JOHN SEUNGJAI 1615 §102§103 Final Rejection — Pending Mar 23, 2023
18027438 SOLUTE-PHASE ELECTROCHEMICAL APTAMER SENSORS FOR IMPROVED LONGEVITY AND SENSITIVITY SUN, CAITLYN MINGYUN 1795 §103§112 Final Rejection — Pending Mar 21, 2023
18027393 CONTINUOUS OPTICAL APTAMER SENSORS FRITCHMAN, REBECCA M 1758 §103 Final Rejection — Pending Mar 21, 2023
18027394 SOLUTE-PHASE APTAMER SENSING WITH APTAMER ISOLATION SUN, CAITLYN MINGYUN 1795 §103 Final Rejection — Pending Mar 21, 2023
18027391 ABRASION PROTECTED MICRONEEDLE AND INDWELLING EAB SENSORS KRETZER, KYLE W. 3791 §102§103 Final Rejection 83d Pending Mar 21, 2023
18069650 METHODS AND COMPOSITIONS FOR THE TREATMENT OF ALS ARON, KIMBERLY A 1633 §103 Final Rejection — Pending Dec 21, 2022
18007516 FEEDBACK PROVIDING FACIAL MASKS ZHANG, TINA 3785 §103 Non-Final OA 73d overdue Pending Dec 01, 2022
17909187 METHODS OF CONTROLLING BODYWEIGHT BY MODULATING PHOSPHATIDYLINOSITOL 5-PHOSPHATE 4-KINASE BETA ACTIVITY PENNINGTON, KATIE LEIGH 1634 §112 Final Rejection — Pending Sep 02, 2022
17799556 Wavelength Supplemented Light Bulbs and Lighting Fixtures LUQUE, RENAN 2896 §102§103 Non-Final OA 3d overdue Pending Aug 12, 2022
17815849 METHOD OF TREATING HER2-POSITIVE BREAST CANCER PERSONS, JENNA L 1637 §112 Final Rejection 4d overdue Pending Jul 28, 2022
17617191 RED BLOOD CELL STORAGE SOLUTIONS, ADDITIVES, AND METHODS FOR IMPROVING THE STORAGE OF RED BLOOD CELLS USING INORGANIC PYROPHOSPHATES BEHARRY, ZANNA MARIA 1632 §103 Final Rejection 8d Pending Dec 07, 2021
17426365 ELECTROCHEMICAL WAVEFORM FOR CALIBRATION-FREE AND BASAL LEVEL SENSING WITH APTASENSORS JOHANNSEN, DIANA B 1682 §101§102§112 Non-Final OA — Pending Jul 28, 2021
17421616 CONTINUOUS EX-VIVO AFFINITY-BASED SENSING OF INTERSTITIAL FLUID TOMBERS, JOSEPH A 3791 §103§112 Non-Final OA 59d overdue Pending Jul 08, 2021
17265718 TEST TO ASSESS LIVER DISEASE SEVERITY IVICH, FERNANDO NMN 1678 §101§103§112 Final Rejection — Pending Feb 03, 2021
16806786 SYSTEM, METHOD COMPUTER PROGRAM PRODUCT AND APPARATUS FOR DYNAMIC PREDICTIVE MONITORING IN THE CRITICAL HEALTH ASSESSMENT AND OUTCOMES STUDY (CHAOS) REYES, REGINALD R 3684 §101 Non-Final OA — Pending Mar 02, 2020

Managing University of Cincinnati's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does University of Cincinnati have?

University of Cincinnati has 41 pending office actions as of October 2026, spread across 33 art units and 40 examiners.

Which USPTO examiner handles the most University of Cincinnati applications?

Caitlyn Mingyun Sun has the most, with 2 of University of Cincinnati's pending office actions.

What technology area are University of Cincinnati's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month